Cargando…

Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET

BACKGROUND: The positron emission tomography (PET) radiotracer [(18)F]MK‐6240 exhibits high specificity for neurofibrillary tangles (NFTs) of tau protein in Alzheimer's disease (AD), high sensitivity to medial temporal and neocortical NFTs, and low within‐brain background. Objectives were to de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shuping, Joanna L., Matthews, Dawn C., Adamczuk, Katarzyna, Scott, David, Rowe, Christopher C., Kreisl, William C., Johnson, Sterling C., Lukic, Ana S., Johnson, Keith A., Rosa‐Neto, Pedro, Andrews, Randolph D., Van Laere, Koen, Cordes, Lindsay, Ward, Larry, Wilde, Claire L., Barakos, Jerome, Purcell, Derk D., Devanand, Davangere P., Stern, Yaakov, Luchsinger, Jose A., Sur, Cyrille, Price, Julie C., Brickman, Adam M., Klunk, William E., Boxer, Adam L., Mathotaarachchi, Sulantha S., Lao, Patrick J., Evelhoch, Jeffrey L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983143/ https://www.ncbi.nlm.nih.gov/pubmed/36873926 http://dx.doi.org/10.1002/trc2.12372

Ejemplares similares

In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240
por: Pascoal, Tharick A., et al.
Publicado: (2018)

The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [(18)F]MK6240 Tau PET in Target Regions
por: Tissot, Cécile, et al.
Publicado: (2023)

Deep learning improves utility of tau PET in the study of Alzheimer's disease
por: Zou, James, et al.
Publicado: (2021)

Optimizing quantification of MK6240 tau PET in unimpaired older adults
por: Harrison, Theresa M., et al.
Publicado: (2023)

Visually Identified Tau (18)F-MK6240 PET Patterns in Symptomatic Alzheimer’s Disease
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Comparing tau status determined via plasma pTau181, pTau231 and [(18)F]MK6240 tau-PET
por: Tissot, Cécile, et al.
Publicado: (2022)

Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue
por: Aguero, Cinthya, et al.
Publicado: (2019)

(18)F-MK-6240 tau-PET in genetic frontotemporal dementia
por: Levy, Jake P, et al.
Publicado: (2021)

Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL (18)F-MK6240 PET study
por: Krishnadas, Natasha, et al.
Publicado: (2023)

Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum
por: Doré, Vincent, et al.
Publicado: (2022)

Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
por: Kunach, Peter, et al.
Publicado: (2023)

Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
por: Malarte, Mona-Lisa, et al.
Publicado: (2020)

Case Report: (18)F-MK6240 Tau Positron Emission Tomography Pattern Resembling Chronic Traumatic Encephalopathy in a Retired Australian Rules Football Player
por: Krishnadas, Natasha, et al.
Publicado: (2020)

Development of a Staff Informant Measure of Lucidity
por: Teresi, Jeanne, et al.
Publicado: (2021)

APPLICATION OF QUALITATIVE METHODS IN THE DEVELOPMENT OF AN INFORMANT-REPORTED MEASURE OF LUCIDITY
por: Ramirez, Mildred, et al.
Publicado: (2022)

Dosimetry and efficacy of a tau PET tracer [(18)F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease
por: Ohnishi, Akihito, et al.
Publicado: (2022)

A dual-time-window protocol to reduce acquisition time of dynamic tau PET imaging using [(18)F]MK-6240
por: Kolinger, Guilherme D., et al.
Publicado: (2021)

Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness
por: Hani Hojjati, Seyed, et al.
Publicado: (2023)

Audiometric Age-Related Hearing Loss and Cognition in the Hispanic Community Health Study
por: Golub, Justin, et al.
Publicado: (2021)

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains
por: Malarte, Mona-Lisa, et al.
Publicado: (2022)

SUBCLINICAL AGE-RELATED HEARING LOSS IS INVERSELY ASSOCIATED WITH DEPRESSIVE SYMPTOMS
por: Golub, Justin S, et al.
Publicado: (2019)

A multicenter comparison of [(18)F]flortaucipir, [(18)F]RO948, and [(18)F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
por: Leuzy, Antoine, et al.
Publicado: (2021)

Relapse in Dementia-related Psychosis and Clinical Decisions
por: Soto-Martin, Maria, et al.
Publicado: (2022)

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial
por: Devanand, D P, et al.
Publicado: (2020)

Apolipoprotein E Genotype e2: Neuroprotection and Its Limits
por: Kim, Hyun, et al.
Publicado: (2022)

Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population
por: Gu, Yian, et al.
Publicado: (2015)

Hearing Loss and Cognitive Decline: Causal Evidence
por: Golub, Justin, et al.
Publicado: (2020)

Computerized Cognitive Training for Major Depressive Disorder: What’s Next?
por: Motter, Jeffrey N., et al.
Publicado: (2015)

Clinical Trials to Gain FDA Approval for Computerized Cognitive Training: What Is the Ideal Control Condition?
por: Motter, Jeffrey N., et al.
Publicado: (2016)

Correction: Reynard, O.; et al. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233‒6240
Publicado: (2016)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
por: Motter, Jeffrey N., et al.
Publicado: (2021)

Constrained instruments and their application to Mendelian randomization with pleiotropy
por: Jiang, Lai, et al.
Publicado: (2019)

Characterizing biomarker features of cognitively normal individuals with ventriculomegaly
por: Li, Xiaofeng, et al.
Publicado: (2017)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Anosognosia predicts default mode network hypometabolism and clinical progression to dementia
por: Therriault, Joseph, et al.
Publicado: (2018)

Chemosensory deficits are best predictor of serologic response among individuals infected with SARS-CoV-2
por: Overdevest, Jonathan B., et al.
Publicado: (2022)

Modification of everyday activities and its association with self-awareness in cognitively diverse older adults
por: Shaked, Danielle, et al.
Publicado: (2019)

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease()
por: Vandenberghe, Rik, et al.
Publicado: (2013)

VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis
por: Mathotaarachchi, Sulantha, et al.
Publicado: (2016)

Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
por: Price, Julie C, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_io1gt52rebqa92mphit0b6q3e1